Supplementation with long chain polyunsaturated fatty acids in treatment of atopic dermatitis in children
- PMID: 24278056
- PMCID: PMC3834680
- DOI: 10.5114/pdia.2013.34160
Supplementation with long chain polyunsaturated fatty acids in treatment of atopic dermatitis in children
Abstract
Some recent studies indicate that unsaturated fatty acids, components of cellular membranes and precursors of immunomodulators, play a significant role in the pathogenesis of some symptoms of atopic dermatitis. Since they cannot be synthesized by the human body, they must be provided with nutrition as the so called exogenous fatty acids: linoleic (a precursor of arachidonic acid) and α-linolenic acid (a precursor of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)). Their deficiency facilitates the development of some disorders, e.g. of the cardiovascular system or of the nervous system, or becomes the cause of intensification of ailments in their course e.g. pruritus and dryness in atopic dermatitis. Though clinical examinations to date confirm the efficacy of fatty acid supplementation in treatment of atopic dermatitis, their results are not explicit.
Keywords: atopic dermatitis; polyunsaturated fatty acids.
References
-
- Karłowicz-Bodalska K, Bodalski T. Long chain polyunsaturated fatty acids – biological properties and the role in treatment. Postępy Fitoterapii. 2007;1:46–56.
-
- Nowicki R, Barańska-Rybak W. Shark liver oil as a additional treatment in atopic dermatitis. Pol Merkur Lekarski. 2007;23:312–3. - PubMed
-
- Jabłońska-Trypuć A, Czerpak R. The metabolism of polyunsaturated fatty acids and the role in prophylaxis and treatment of blood diseases. Przegl Kardiodiabetol. 2009;4:55–63.
-
- Statement on supplementation with docosahexaenoic and omega-3 acids in population of pregnant and breast-feeding women and infants and children up to three years. Postępy Neonatologii. 2011:1.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials